PREDICTING ATRIAL FIBRILLATION RECURRENCE BY PROTEASE AND PROTEASE INHIBITOR PROFILING

摘要

Disclosed herein are methods of and systems for predicting recurrence of atrial fibrillation comprising protease and protease inhibitor profiling. The levels of matrix metalloproteinases (MMPs) and/or tissue inhibitor metalloproteinases (TIMPs) are analyzed to predict the recurrence of atrial fibrillation, and further to predict whether cardioversion will provide a successful therapy.